Medical Cannabis - Colombia

Colombia

Colombia's Medical Cannabis market market is forecasted to reach €17.76m in 2024.
The market is anticipated to demonstrate a Compound Annual Growth Rate (CAGR 2024-2029) of 4.75%, leading to a market volume of €22.40m by 2029.
When compared globally, the United States is expected to generate the highest revenue (€13,470.00m in 2024).
In terms of per person revenues in 2024, €0.54k is generated relative to the total population.
Colombia's medical cannabis market is blooming with new regulations attracting international investors and promising significant growth potential.

Key regions: Australia, Europe, South Africa, United States, Netherlands

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

Colombia has emerged as a key player in the global Medical Cannabis market, showcasing significant growth and potential.

Customer preferences: Customers in Colombia are increasingly turning to Medical Cannabis products as an alternative form of treatment due to the growing acceptance of its therapeutic benefits. The shift towards natural and holistic remedies is influencing consumer preferences, driving the demand for Medical Cannabis products in the country.

Trends in the market: One notable trend in the Colombian Medical Cannabis market is the emphasis on research and development. Local companies are investing in innovation to create new and improved products that cater to a wide range of medical conditions. This focus on product development is not only meeting the needs of domestic consumers but also positioning Colombia as a hub for Medical Cannabis research in the region.

Local special circumstances: Colombia's unique climate and geographical conditions provide a competitive advantage for the cultivation of Medical Cannabis. The country's equatorial location offers abundant sunlight and ideal temperatures for outdoor cultivation, resulting in high-quality yields at lower production costs. Additionally, Colombia's rich history in agriculture and experience in cultivating crops further supports the growth of the Medical Cannabis industry.

Underlying macroeconomic factors: The liberalization of regulations surrounding Medical Cannabis in Colombia has been a key driver of market growth. The government's progressive stance on legalization and its support for the industry have created a favorable environment for businesses to thrive. This regulatory framework, coupled with the country's strategic location for export to other Latin American markets, has attracted significant investment in the Medical Cannabis sector, paving the way for further expansion and development.

Methodology

Data coverage:

Data encompasses B2B and B2C enterprises. Figures are based on companies' revenues, funding values and global consumer survey data. Revenues include retail, sales and taxes.

Modeling approach / Market size:

Market sizes are determined by a Top-Down approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports, third-party data. Next, we use relevant key market indicators and data from country-specific associations such as tobacco spending per capita, medical product spending per capita, consumer spending and consumer spending for recreation purposes, population. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.